GKOS
USDGlaukos Corporation Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$85.860
Максимум
$88.290
Минимум
$85.235
Объем
0.50M
Фундаментальные показатели компании
Рыночная капитализация
4.9B
Отрасль
Медицинские приборы
Страна
United States
Статистические данные торговли
Средний объем
1.05M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Связанные новости
Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its
JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $120
JP Morgan analyst Allen Gong maintains Glaukos with a Overweight and raises the price target from $110 to $120.
Citigroup Maintains Buy on Glaukos, Raises Price Target to $113
Citigroup analyst Joanne Wuensch maintains Glaukos with a Buy and raises the price target from $110 to $113.
Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $122
Wells Fargo analyst Larry Biegelsen maintains Glaukos with a Overweight and raises the price target from $120 to $122.
Needham Maintains Buy on Glaukos, Raises Price Target to $117
Needham analyst David Saxon maintains Glaukos with a Buy and raises the price target from $115 to $117.
BTIG Maintains Buy on Glaukos, Raises Price Target to $116
BTIG analyst Ryan Zimmerman maintains Glaukos with a Buy and raises the price target from $104 to $116.
Glaukos Announces Third Quarter 2025 Financial Results
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.